Langan Joins Thought Leader Select Research Group

February 26, 2013 · Leave a comment

For Immediate Release

February 21, 2013 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina-based key opinion leader strategy company, announces the hiring of Heather Langan as research director.

In her new role at the company, Langan will lead profiling and engagement planning related to the skills and experience of both leading physicians and other health care professionals, as well as medical centers of excellence that advance the medical science.  Life sciences companies use this research and advice for better strategic decision-making for collaborations with medical experts, as industry works with these experts to bring new treatments to market for better patient care and better public health outcomes.

Langan arrives at Thought Leader Select after a decorated career in human services, working and leading teams in developmental disabilities, family therapy, and mental health.  In her most recent role at Duke University’s National Center for Child Traumatic Stress, Langan led quality assurance and continuous improvement at the premier center of excellence in the area of child trauma, influencing the treatment decisions in evidence-based clinics around the country.

Heather Langan holds two bachelor’s degrees, in philosophy and psychology, from the University of Utah.  After graduation, Langan also earned a pair of master’s degrees in psychology and counseling, from Stephen F. Austin University and North ... read more »

TAGS:                                           

The Necessity of Quality Measures When Profiling Thought Leaders in Medicine

October 23, 2012 · Leave a comment

Industry Insights from Paul Meade, M.Sc., MPH

There are several companies that claim to identify and profile key opinion leaders in healthcare, and they using an array of methodologies and techniques to arrive at defining the practitioners who drive a given therapeutic area or disease state. And yet, while all claim to have built a better mousetrap for profiling these thought leaders, what is sadly lacking among many these vendors is quality control and good quality measures.

Notwithstanding the variety of definitions of a key opinion leader emblematic of the lack of standardization across the industry, there is also a wide variation in the quality of the output from one vendor to the next. For instance, some companies utilize automated web-crawlers (think: glorified Google Alerts) to mine public information—for the most part, scientific publications data, and simply foist upon their clients a “data dump.” The content of these data dumps is often completely devoid of sound quality control—for example, it is not uncommon for an IT-based vendor to offer up John Smith, John D. Smith, and JD Smith as three separate KOLs, when, in reality, Dr. John D. Smith is a true one-of-a-kind. Likewise, we have also seen lists where vendors may conflate Dr. David Lee from Sacramento with Dr. David Lee from Shanghai, when human researchers would see these to ... read more »

TAGS:                                                 

Top US Pharma Chooses Thought Leader Select for Obesity KOL Initiative

October 4, 2012 · Leave a comment

(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in obesity with a top U. S. biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with scientific advisory boards, consulting, and medical science liaison outreach to leading physicians in this area.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes, the company has now chosen Thought Leader Select to pinpoint the leading experts in the treatment of obesity in the United States.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.

Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the area of obesity, and a suite of tools to promote collaborative work ... read more »

TAGS:                                             

Predictions for Healthcare in 2012

February 21, 2012 · Leave a comment

Industry Insights from Paul Meade, M. Sc., MPH

While the Mayans might have been good at developing a cosmic calendar with 27,000-year cycles, I will try to venture only one or two years out and predict some developments within the healthcare system.

I dare say the Mayans had great foresight about changes, even if they never invented the wheel, but clearly they missed the fact that 2012 was an election year in the United States, and that predicting change became no mean task with orders of magnitude of difficulty. Nonetheless, I will attempt to gaze into my crystal ball and give my predictions for the next little while.

The promise of personalized medicine has been swirling around in the minds of brilliant people for well over a decade now, but we are patiently awaiting the results to impact our daily lives. Throughout the past 10-15 years, advances in the personalized medicine field have been somewhat slow to appear on the landscape. We should not be too discouraged by this advancing timeline, since we are still waiting for a cure for cancer after many decades of highly-funded research. Yet, each day, scientists are discovering more and more biomarkers with the potential to move us closer the reality of personalized medicine.

These biomarkers are not only predicting diseases—they are identifying companion diagnostics, indicating response levels to ... read more »

TAGS:                                 

Thought Leader Select Begins Skin Cancer KOL Assessment for Top Five Global Pharmaceutical Company

February 16, 2012 · Leave a comment

Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement of a key opinion leader assessment for a top five global pharmaceutical company.

For the assessment, Thought Leader Select will use its proprietary identification methodology to pinpoint 40 Canadian key opinion leaders in oncology, with sub-specialty in the area of skin cancer. The company will study the skills and experience of Canadian oncologists in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.

The client company will utilize Thought Leader Select’s research to engage key opinion leaders in oncology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.

“We are excited about this opportunity to support a great company as they prepare to enter the Canadian market with a new medicine that will improve the lives of patients suffering from skin cancer,” stated Neil Mellor, Thought Leader Select’s global business development consultant.  “Our position in the advancement of this new treatment is critical, since our work ensures that the company will be reaching out to the right physicians during the company’s earliest phase of assisting in the treatment of patients in this disease area.”

About Neil Mellor

Neil Mellor is ... read more »

TAGS:                                                 

Thought Leader Select Seeking New Sales Executive in U.S. Market

February 8, 2012 · Leave a comment

Thought Leader Select is looking for a dynamic, talented individual to fill its newest U.S. Sales Executive position.

Founded in 2006, Thought Leader Select is a firm that serves the biopharmaceutical industry by providing strategic counsel on the best ways to work with medical experts (known as “thought leaders” and “key opinion leaders”) and assessing experts within a host of therapeutic areas such as diabetes, oncology, and neurology.

Interested applicants should go to the company’s human resources site for more information on this exciting opportunity.

TAGS:                   

Thought Leader Select Announces Key Opinion Leader Assessments in Chronic Pain, Colorectal Surgery, and Gastroenterology

February 2, 2012 · Leave a comment

New Press Release from the Offices of Thought Leader Select

February 2, 2012 (Chapel Hill, NC) Thought Leader Select is pleased to announce a pair of key opinion leader (KOL) identification and profiling projects to support the development pipeline of a leading pharmaceutical client focused in the therapeutic area of gastroenterology.

In the first research assessment, Thought Leader Select will identify and profile leading medical experts in the treatment of patients suffering from non-cancer-related chronic pain.  The company will identify the leading pain experts throughout the United States by examining the skills and experiences of physicians in multiple disciplines and specialties, including gastroenterologists, primary care physicians, nurse practitioners, and physician assistants.

For the second research assessment, Thought Leader Select will identify and profile 100 key opinion leaders in colorectal surgery, as well as 125 KOLs in gastroenterology. The cumulative group of 225 physician thought leaders will share vast experience in research and treatment of fecal incontinence.

Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders chronic pain, colorectal surgery, and gastroenterology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research.  The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in ... read more »

TAGS:                                                   

Thought Leader Select Announces New KOL Identification and Profiling Projects in Oncology, Neurology

December 2, 2011 · Leave a comment

Thought Leader Select is pleased to announce a series of key opinion leader (KOL) identification and profiling projects to support multiple therapeutic areas for a top five global biopharmaceutical company.

In these research assessments, Thought Leader Select will identify and profile leading medical experts in neurology and oncology to support drug development initiatives in various cancers and neurological disorders. The oncologists and neurologists will represent many of the leading physicians at top medical centers of excellence throughout Canada.

Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders in oncology and neurology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research.  The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in medical research and clinical settings in the United States, Canada, Australia, and Africa.

The project will yield over 100 physicians who may advise the company on its development efforts in the treatment of cancers and neurological diseases. Typically, key opinion leaders serve on scientific advisory boards and participate in late-stage clinical trials to monitor the effectiveness of new drugs in larger patient populations.

“We are honored that this company has chosen to partner with us again to use effective solutions to identify ... read more »

TAGS:                                                         

Thought Leader Select Announces New Assessments of Key Opinion Leaders, Centers of Excellence in Women’s Health, Oncology

October 28, 2011 · Leave a comment

Company News

Thought Leader Select is pleased to announce a pair of projects in support of a top 10 global biopharmaceutical company as it seeks to develop a portfolio of medicines in women’s health.

For the assessments, Thought Leader Select will study key opinion leaders and medical centers of excellence in the treatment of cancers affecting the gynecological health of women, specifically ovarian cancer, cervical cancer, and uterine cancer. In the first assessment, the company will identify and profile Canadian oncologists with vast expertise in research and treatment of these cancers affecting women.  In the second assessment, Thought Leader Select will identify and profile Canadian medical centers with specialized infrastructures for research and treatment in these disease areas.

“We are very proud to begin this critical work supporting pharmaceutical development in the area of women’s health,” stated Neil Mellor, Thought Leader Select’s global business development consultant.  “This client is an established leader in developing medicines for the treatment of various forms of cancer, and we appreciate the opportunity to help them partner with the right key opinion leaders and centers of excellence in women’s health and oncology, to ultimately help patients suffering from these cancers.”

TAGS:                                                 

Thought Leader Select Completes Multi-specialty Key Opinion Leader Assessment in Aging

October 21, 2011 · Leave a comment

Company News

Thought Leader Select announces the delivery of a multi-specialty key opinion leader assessment in aging. The firm, based in Chapel Hill, North Carolina, was retained by a top 10 global pharmaceutical company to assess the skills and experiences of physicians specializing in the treatment of the following diseases and conditions that primarily affect the over-65 population:

• Chronic Pain

• Osteoarthritis

• Alzheimer’s Disease

• Parkinson’s Disease

The company will be collaborating with a host of medical experts to gain further development of a portfolio of new medicines in these areas.  Thought Leader Select has identified key opinion leaders in each of these areas in order to reach a roster of 100 U.S. key opinion leaders in diseases and conditions affecting the senior population.

“We are very pleased that this company has chosen to work with us on this fascinating project,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “They chose us because they wanted to do two things—work with skilled physicians who have high quality, relevant experience in treating the aging population in the U.S., and they wanted to do that in the most compliant manner possible. Our validated, objective methodology, in-depth profiling, ensures that they will be working with the right physicians at the right times for the right reasons.”

TAGS:                                           

Older posts »